HeartWorks and Mayo Clinic launch a clinical trial that involves surgically injecting lab-grown cardiac tissue—sourced from the patients’ skin cells—in people with congenital heart disease.

Double Infection: How HeartWorks Stretches Every Dollar in Heart Cell Manufacturing
Discover how HeartWorks is improving personalized heart cell manufacturing by increasing efficiency, reducing costs, and advancing therapies for congenital heart disease.

